Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 17 studies | 33% ± 17% | |
ciliated cell | 15 studies | 47% ± 20% | |
classical monocyte | 10 studies | 22% ± 5% | |
smooth muscle cell | 7 studies | 23% ± 9% | |
alveolar macrophage | 6 studies | 39% ± 11% | |
macrophage | 5 studies | 37% ± 19% | |
myofibroblast cell | 5 studies | 40% ± 14% | |
hepatocyte | 4 studies | 74% ± 14% | |
duct epithelial cell | 3 studies | 31% ± 7% | |
pericyte | 3 studies | 26% ± 7% | |
cholangiocyte | 3 studies | 47% ± 18% | |
endothelial cell | 3 studies | 38% ± 17% | |
type II pneumocyte | 3 studies | 21% ± 4% | |
monocyte | 3 studies | 25% ± 4% | |
connective tissue cell | 3 studies | 16% ± 0% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 40542.49 | 226 / 226 | 96% | 1857.92 | 388 / 406 |
lung | 100% | 10909.22 | 578 / 578 | 76% | 342.35 | 879 / 1155 |
prostate | 89% | 2460.52 | 217 / 245 | 79% | 30.05 | 396 / 502 |
bladder | 100% | 3856.00 | 21 / 21 | 28% | 99.91 | 141 / 504 |
uterus | 92% | 3292.24 | 157 / 170 | 21% | 64.59 | 95 / 459 |
esophagus | 83% | 2846.06 | 1198 / 1445 | 30% | 188.45 | 55 / 183 |
breast | 83% | 2958.83 | 382 / 459 | 29% | 10.93 | 328 / 1118 |
intestine | 81% | 3627.30 | 780 / 966 | 28% | 21.51 | 150 / 527 |
blood vessel | 98% | 4287.01 | 1308 / 1335 | 0% | 0 | 0 / 0 |
adipose | 87% | 4800.25 | 1046 / 1204 | 0% | 0 | 0 / 0 |
pancreas | 10% | 125.85 | 34 / 328 | 76% | 61.47 | 135 / 178 |
heart | 81% | 2178.24 | 699 / 861 | 0% | 0 | 0 / 0 |
spleen | 81% | 2234.93 | 195 / 241 | 0% | 0 | 0 / 0 |
stomach | 39% | 1387.35 | 140 / 359 | 33% | 30.20 | 95 / 286 |
ovary | 63% | 1233.94 | 114 / 180 | 4% | 0.95 | 18 / 430 |
thymus | 39% | 530.44 | 255 / 653 | 26% | 10.06 | 159 / 605 |
skin | 52% | 776.70 | 937 / 1809 | 7% | 2.60 | 33 / 472 |
adrenal gland | 41% | 782.15 | 107 / 258 | 10% | 8.66 | 24 / 230 |
peripheral blood | 50% | 1062.93 | 468 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 38% | 16.97 | 11 / 29 |
kidney | 16% | 165.84 | 14 / 89 | 15% | 6.18 | 134 / 901 |
eye | 0% | 0 | 0 / 0 | 10% | 2.70 | 8 / 80 |
tonsil | 0% | 0 | 0 / 0 | 9% | 22.53 | 4 / 45 |
brain | 0% | 3.59 | 9 / 2642 | 3% | 0.72 | 20 / 705 |
muscle | 2% | 23.58 | 18 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0010887 | Biological process | negative regulation of cholesterol storage |
GO_0030855 | Biological process | epithelial cell differentiation |
GO_0008203 | Biological process | cholesterol metabolic process |
GO_0043691 | Biological process | reverse cholesterol transport |
GO_0090205 | Biological process | positive regulation of cholesterol metabolic process |
GO_0016042 | Biological process | lipid catabolic process |
GO_0090122 | Biological process | cholesterol ester hydrolysis involved in cholesterol transport |
GO_0120188 | Biological process | regulation of bile acid secretion |
GO_0071404 | Biological process | cellular response to low-density lipoprotein particle stimulus |
GO_0051791 | Biological process | medium-chain fatty acid metabolic process |
GO_0071397 | Biological process | cellular response to cholesterol |
GO_0010875 | Biological process | positive regulation of cholesterol efflux |
GO_0070857 | Biological process | regulation of bile acid biosynthetic process |
GO_0009636 | Biological process | response to toxic substance |
GO_0006695 | Biological process | cholesterol biosynthetic process |
GO_0042632 | Biological process | cholesterol homeostasis |
GO_0005811 | Cellular component | lipid droplet |
GO_0005788 | Cellular component | endoplasmic reticulum lumen |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0106435 | Molecular function | carboxylesterase activity |
GO_0052689 | Molecular function | carboxylic ester hydrolase activity |
GO_0047374 | Molecular function | methylumbelliferyl-acetate deacetylase activity |
GO_0004771 | Molecular function | sterol esterase activity |
Gene name | CES1 |
Protein name | Carboxylesterase 1 Liver carboxylesterase 1 Liver carboxylesterase 1 (Acyl-coenzyme A:cholesterol acyltransferase) (ACAT) (Brain carboxylesterase hBr1) (Carboxylesterase 1) (CE-1) (hCE-1) (EC 3.1.1.1) (Cholesteryl ester hydrolase) (CEH) (EC 3.1.1.13) (Cocaine carboxylesterase) (Egasyn) (HMSE) (Methylumbelliferyl-acetate deacetylase 1) (EC 3.1.1.56) (Monocyte/macrophage serine esterase) (Retinyl ester hydrolase) (REH) (Serine esterase 1) (Triacylglycerol hydrolase) (TGH) |
Synonyms | CES2 SES1 |
Description | FUNCTION: Involved in the detoxification of xenobiotics and in the activation of ester and amide prodrugs . Hydrolyzes aromatic and aliphatic esters, but has no catalytic activity toward amides or a fatty acyl-CoA ester . Hydrolyzes the methyl ester group of cocaine to form benzoylecgonine . Catalyzes the transesterification of cocaine to form cocaethylene . Displays fatty acid ethyl ester synthase activity, catalyzing the ethyl esterification of oleic acid to ethyloleate . Converts monoacylglycerides to free fatty acids and glycerol. Hydrolyzes of 2-arachidonoylglycerol and prostaglandins . Hydrolyzes cellular cholesteryl esters to free cholesterols and promotes reverse cholesterol transport (RCT) by facilitating both the initial and final steps in the process . First of all, allows free cholesterol efflux from macrophages to extracellular cholesterol acceptors and secondly, releases free cholesterol from lipoprotein-delivered cholesteryl esters in the liver for bile acid synthesis or direct secretion into the bile . . |
Accessions | A0A140TA63 ENST00000563241.5 ENST00000574235.1 ENST00000422046.6 [P23141-3] ENST00000360526.8 [P23141-2] H3BQR4 H3BQV8 ENST00000361503.8 [P23141-1] ENST00000561966.2 ENST00000576185.1 ENST00000569260.1 ENST00000574513.5 H3BSU0 P23141 ENST00000565568.1 ENST00000576783.5 ENST00000571922.5 |